# Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain

> **NCT06632730** · — · COMPLETED · sponsor: **Novartis** · enrollment: 69 (actual)

## Conditions studied

- Spinal Muscular Atrophy Type I
- Spinal Muscular Atrophy Type II

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06632730
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-05
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06632730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06632730, "Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06632730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*